2-(1H-Imidazol-1-yl)pyridine

Catalog No. :
ACVIRL251
CAS No. :
25700-14-5
Molecular Formula :
C8H7N3
Molecular Weight :
145.16

IUPAC Name:2-(1H-imidazol-1-yl)pyridine

2-(1H-Imidazol-1-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$87.00Login to see priceIn stockIn stock
5g97%$226.00Login to see priceIn stockIn stock
10g97%$394.00Login to see priceIn stockIn stock
25g97%$787.00Login to see priceIn stockInquiry
100g97%$2515.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1H-Imidazol-1-yl)pyridine
IUPAC Name2-(1H-imidazol-1-yl)pyridine
MDL No.MFCD06253569
Molecular FormulaC8H7N3
Molecular Weight145.16
SMILESC1(N2C=CN=C2)=NC=CC=C1
InChI KeyMIJZSNMJNBVCEB-UHFFFAOYSA-N
SynonymAKOS BBS-00000367;2-IMIDAZOL-1-YL-PYRIDINE;Pyridine,2-(1H-iMidazol-1-yl)-;2-(1H-Imidazol-1-yl)pyridine;N-(2-Pyridyl)imidazole;2-(1H-imidazolyl)pyridine;pyridin-2-yl imidazole
CAS No.25700-14-5
PubChem CID589257

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACVIRL251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHXR638 route compound structure diagram
    ACFHXR638109-04-6 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACVIRL251 route product structure diagram
    ACVIRL25125700-14-5 In Stock
Inquiry

2. ACVIRL251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRAI571 route compound structure diagram
    ACLRAI5715029-67-4 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACVIRL251 route product structure diagram
    ACVIRL25125700-14-5 In Stock
Inquiry

Comments (0)